Effectiveness of BCG vaccination in protecting possums against bovine tuberculosis.
Three groups of eight possums were vaccinated with BCG Pasteur by the subcutaneous, intratracheal or intragastric routes, with a fourth group serving as unvaccinated controls. Forty-two days after the start of vaccination, five possums from each group were challenged intratracheally with virulent Mycobacterium bovis. The vaccination by the subcutaneous or intratracheal routes resulted in a marked reduction in the severity of disease compared with the unvaccinated animals or the animals vaccinated intragastrically. The severity of the disease was assessed by changes in bodyweight, pathological changes in the lungs and bronchial nodes and the number of acid-fast bacilli in the lesions. Before the challenge, lymphocyte blastogenic responses to bovine PPD were observed in the eight animals vaccinated subcutaneously and in two of the animals vaccinated intratracheally.
Aldwell
F E
FE
AgResearch, Wallaceville Animal Research Centre, Upper Hutt, New Zealand.
Pfeffer
A
A
DeLisle
G W
GW
Jowett
G
G
Heslop
J
J
Keen
D
D
Thomson
A
A
Buddle
B M
BM
D000818:Animals; D001500:BCG Vaccine / Q000008:administration & dosage; D007279:Injections, Subcutaneous / Q000662:veterinary; D007441:Intubation, Gastrointestinal / Q000662:veterinary; D007442:Intubation, Intratracheal / Q000662:veterinary; D008213:Lymphocyte Activation; D008297:Male; D009163:Mycobacterium bovis; D009893:Opossums / Q000276:immunology* / Q000382:microbiology*; D014376:Tuberculosis / Q000473:pathology / Q000517:prevention & control / Q000662:veterinary*; D014611:Vaccination / Q000662:veterinary*
D001500:BCG Vaccine